Eric V Balti
Overview
Explore the profile of Eric V Balti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
262
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Van Dalem A, Demeester S, Balti E, Keymeulen B, Gillard P, Lapauw B, et al.
PLoS One
. 2017 Jun;
12(6):e0179108.
PMID: 28570714
[This corrects the article DOI: 10.1371/journal.pone.0166702.].
12.
Van Dalem A, Demeester S, Balti E, Keymeulen B, Gillard P, Lapauw B, et al.
PLoS One
. 2016 Dec;
11(12):e0166702.
PMID: 27907006
Background: The hyperglycemic clamp test, the gold standard of beta cell function, predicts impending type 1 diabetes in islet autoantibody-positive individuals, but the latter may benefit from less invasive function...
13.
Nansseu J, Ngo-Um S, Balti E
Syst Rev
. 2016 Nov;
5(1):188.
PMID: 27832816
Background: In the absence of existing data, the present review intends to determine the incidence, prevalence and/or genetic determinants of neonatal diabetes mellitus (NDM), with expected contribution to disease characterization....
14.
Yako Y, Guewo-Fokeng M, Balti E, Bouatia-Naji N, Matsha T, Sobngwi E, et al.
Diabetes Res Clin Pract
. 2016 Feb;
114:136-50.
PMID: 26830076
Background: Type 2 diabetes (T2D) is growing faster in Africa than anywhere else, driven by the dual effects of genetic and environmental factors. We conducted a systematic review and meta-analyses...
15.
Van Dalem A, Demeester S, Balti E, Decochez K, Weets I, Vandemeulebroucke E, et al.
Diabetologia
. 2015 Sep;
58(12):2753-64.
PMID: 26409458
Aims/hypothesis: We examined whether measures of glycaemic variability (GV), assessed by continuous glucose monitoring (CGM) and self-monitoring of blood glucose (SMBG), can complement or replace measures of beta cell function...
16.
Nansseu J, Fokom-Domgue J, Noubiap J, Balti E, Sobngwi E, Kengne A
BMJ Open
. 2015 May;
5(5):e007689.
PMID: 25979870
Introduction: Fructosamine is a marker of glucose control reflecting the average glycaemic level over the preceding 2-3 weeks. Fructosamine has not gained as much popularity as glycated haemoglobin (HbA1c) for...
17.
Veigne S, Sobngwi E, Nouthe B, Sobngwi-Tambekou J, Balti E, Limen S, et al.
Cardiovasc J Afr
. 2015 Mar;
26(1):38-40.
PMID: 25784316
We measured the glycated haemoglobin (HbA1c) levels of a total of 24 non-diabetic volunteers and diabetic patients using a point-of-care (POC) analyser in three Cameroonian cities at different altitudes. Although...
18.
Demeester S, Keymeulen B, Kaufman L, Van Dalem A, Balti E, Van de Velde U, et al.
Diabetes Care
. 2015 Jan;
38(4):644-51.
PMID: 25583753
Objective: Immune intervention trials in recent-onset type 1 diabetes would benefit from biomarkers associated with good therapeutic response. In the previously reported randomized placebo-controlled anti-CD3 study (otelixizumab; GlaxoSmithKline), we tested...
19.
Balti E, Ngo-Nemb M, Lontchi-Yimagou E, Atogho-Tiedeu B, Effoe V, Akwo E, et al.
Diabetes Res Clin Pract
. 2014 Dec;
107(1):31-6.
PMID: 25511714
Aim: We investigated the association of HLA DRB1 and DQB1 alleles, haplotypes and genotypes with unprovoked antibody-negative ketosis-prone atypical diabetes (A(-) KPD) in comparison to type 2 diabetes (T2D). Methods:...
20.
Balti E, Vandemeulebroucke E, Weets I, Van de Velde U, Van Dalem A, Demeester S, et al.
J Clin Endocrinol Metab
. 2014 Nov;
100(2):551-60.
PMID: 25405499
Context And Objective: In preparation of future prevention trials, we aimed to identify predictors of 3-year diabetes onset among oral glucose tolerance test (OGTT)- and hyperglycemic clamp-derived metabolic markers in...